Proteoglycans. The architecture of resilience.

A proteoglycan consists of a protein core with long carbohydrate chains called glycosaminoglycans attached to it. Its architecture is often compared with a bottlebrush: a central backbone surrounded by many projecting chains.

These chains carry electrical charges and interact with water. In cartilage, proteoglycans function within a collagen network, contributing to resistance to compression and the ability to bear loads.

The collagen framework and the water-rich space within it together give cartilage its mechanical properties.

Proteoglycans also occur in skin, where they help organise the extracellular matrix. They form a large molecular family, with structures and functions that vary between tissues. Research on food ingredients therefore needs to identify the particular material, its source and how it was prepared.

Salmon nasal-cartilage proteoglycan has an unusual history. Researchers at Hirosaki University took inspiration from hizu namasu, a traditional dish made with thinly sliced salmon cartilage and vinegar.

According to the university, this local food inspired Professor Takagaki’s development of an extraction method using food-grade acetic acid in 1998. Collaboration between university researchers and industrial partners helped make the material available for further investigation and functional-ingredient production.

The supplied documentation describes Proteoglycan F as a dried, proteoglycan-containing ingredient obtained from salmon nasal cartilage. Behind a familiar line on a product’s ingredient list lies a sequence of technological steps: extraction, purification, standardisation and production of a powder.

Studies of orally consumed proteoglycan examine specific skin parameters.

In a randomised, double-blind study published in 2015, Tatsuji Takahashi and colleagues assigned 19 adults to proteoglycan or placebo.

The authors reported improvements in selected skin-elasticity measurements compared with placebo. They also assessed hydration, surface condition and other parameters. The small sample limits the reach of the findings, but the study illustrates how an ingredient can be investigated through instrumental measurements alongside participants’ experiences.

A more recent Proteoglycan F trial appeared in Osteoarthritis and Cartilage Open in 2024. Huyen Thi Thanh Vu’s team included Vietnam’s National Geriatric Hospital, Hanoi Medical University and Japanese researchers.

The randomised, double-blind trial compared proteoglycan with placebo over 24 weeks. The test serving supplied 10 mg of proteoglycan daily: the amount of proteoglycan itself under the trial conditions.

Researchers assessed symptoms, quality of life, laboratory measures, ultrasound and knee MRI. More proteoglycan recipients met specified pain-reduction criteria. Certain MRI scores for subchondral bone — the area beneath the cartilage — also improved more in that group.

Ultrasound characteristics did not differ significantly between groups. The authors called for further research. These findings do not establish regeneration of lost cartilage.

In February 2026, Shintaro Hirasawa and Tomio Yabe of Gifu University investigated another question: could proteoglycan interact directly with intestinal epithelial cells? The fate of these large molecules after oral intake remains under investigation.

Using Caco-2 cells as a laboratory model, the researchers found changes in TIMP gene expression and gelatinase activity, part of the regulation of extracellular-matrix enzymes. The proteoglycan came from the manufacturer identified in the supplied ingredient dossier.

The work proposes an intestinal interaction that does not first require the entire molecule to enter the bloodstream. This is a cell study: it develops a possible mechanism, without establishing a clinical effect in humans.

Within the Yotsuba Japan collection, proteoglycan-containing ingredients appear in three products with different formulation directions.

N-Acetylglucosamine combines it with N-acetylglucosamine, undenatured type II collagen, knotweed extract and MSM. Here, proteoglycan forms part of a composition focused on joints and mobility.

Collagen Tripeptide brings proteoglycan together with collagen tripeptides, hyaluronic acid, rice ceramides, fish elastin and vitamins. In this formula, it belongs to the beauty-from-within direction.

Elixir Collagen Drink combines salmon proteoglycan with fish collagen peptides, swallow’s nest, silk peptide and selected beauty ingredients.

Proteoglycan connects the three compositions while each retains its own character. This is what makes proteoglycans so interesting: their architecture, origin, preparation and the specific questions researchers continue to ask.